Elevance Health (ELV) Fell Due to Reduced Guidance

1 week ago 6

Soumya Eswaran

Thu, January 8, 2026 astatine 6:55 AM CST 2 min read

Impax Asset Management, an concern absorption company, released its “Impax US Sustainable Economy Fund” third-quarter 2025 capitalist letter. A transcript of the missive tin beryllium downloaded here. In Q3 2025, the portfolio lagged down the Russell 1000. Similar to the 2nd quarter, the US equity markets favored a risk-on approach, benefiting high-risk, high-momentum, and lower-quality factors. Although the portfolio’s absorption connected comparatively modest, lower-risk, and high-quality factors contributed to the underperformance, the money (Institutional Class) returned 7.33% successful Q3 compared to 7.99% for the Index. In addition, you tin cheque the fund’s apical 5 holdings to find its champion picks for 2025.

In its third-quarter 2025 capitalist letter, Impax US Sustainable Economy Fund highlighted stocks specified arsenic Elevance Health, Inc. (NYSE:ELV). Elevance Health, Inc. (NYSE:ELV) is simply a wellness benefits company. The one-month instrumentality of Elevance Health, Inc. (NYSE:ELV) was 1.80%, and its shares mislaid 4.32% of their worth implicit the past 52 weeks. On January 7, 2026, Elevance Health, Inc. (NYSE:ELV) banal closed astatine $366.69 per share, with a marketplace capitalization of $82.571 billion.

Impax US Sustainable Economy Fund stated the pursuing regarding Elevance Health, Inc. (NYSE:ELV) successful its 3rd 4th 2025 capitalist letter:

"Elevance Health, Inc. (NYSE:ELV) (Health Care, Managed Health Care) has a precocious Corporate Resilience Score and is aligned to the Health Access and Innovation theme. The banal was weaker aft the institution guided afloat twelvemonth net estimates down implicit 10% arsenic a effect of accrued costs successful the Medicaid and Affordable Care Act program channels."

Elevance Health (ELV) Drops 18.66% After Dismal Q2 Earnings

Elevance Health, Inc. (NYSE:ELV) is not connected our database of 30 Most Popular Stocks Among Hedge Funds. As per our database, 82 hedge money portfolios held Elevance Health, Inc. (NYSE:ELV) astatine the extremity of the 3rd quarter, which was 67 successful the erstwhile quarter. In Q3 2025, Elevance Health, Inc. (NYSE:ELV) reported $50.1 cardinal of operating revenue, an summation of 12% year-over-year. While we admit the imaginable of Elevance Health, Inc. (NYSE:ELV) arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

In another article, we covered Elevance Health, Inc. (NYSE:ELV) and shared the database of Artisan Value Fund's views connected the company. In addition, delight cheque retired our hedge money capitalist letters Q3 2025 page for much capitalist letters from hedge funds and different starring investors.